BCL11A Is Oncogenic and Predicts Poor Outcomes in Natural Killer/T-Cell Lymphoma

The current treatment for natural killer/T-cell lymphoma (NKTL) among advanced/relapsed patients is unsatisfying, thereby highlighting the need for novel therapeutic targets. B‐cell chronic lymphocytic leukemia/lymphoma 11 A (BCL11A), as a transcription factor, is oncogenic in several neoplasms. How...

Full description

Saved in:
Bibliographic Details
Published in:Front Pharmacol
Main Authors: Shi, Hongyun, Li, Chun, Feng, Wei, Yue, Jianjun, Song, Jingfang, Peng, Aizhi, Wang, Hua
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2020
Subjects:
Pharmacology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7311857/
https://ncbi.nlm.nih.gov/pubmed/32625084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00820
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items